Adjusted gross margin is expected to land between 45% and 47%. Adjusted EBITDA is anticipated to be between $135 million to $155 million. Net income is expected to be between a loss of $30 million and ...
Management expects cash burn to hold steady through 2026 and start declining by the end of next year, driven by increasing Attruby revenues and improved operating leverage. Kumar said, "Our current ...
Hosted on MSN
Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements
Earnings Call Insights: Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Lakkaraju provided 2026 non-GAAP guidance, stating "We are guiding currency-neutral revenue growth for the full year to be between 0.5% ...
Do the Impossible," PBS aims to tell the story of a man who defied conventionality as naturally as he breathed.
The ‘Supergirl’ star stepped out with Powell on this year’s red carpet. Here’s what to know about their relationship.
Biobased testing reveals the percentage of biobased versus fossil carbon content in a given sample.Biobased carbon testing helps manufacturers develop materials that mee ...
I Give You My Silence is by no means a top-drawer, career-high Mario Vargas Llosa novel, but it has more than enough merits.
Star Trek: Enterprise featured one of the franchise's most underrated characters in Jonathan Archer. However, the captain of ...
PDRN was first developed by South Korean scientists researching wound healing. Korean dermatology clinics adopted the ingredient early - injectable PDRN treatments became a widely used procedure in ...
For decades, early-stage biotech and medtech companies operated on a familiar model: raise capital, advance the science, reach regulatory milestones, and ...
France’s consumer authority has set out how food packaging must meet EU safety rules to avoid harmful chemicals leaking into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results